126 related articles for article (PubMed ID: 24576777)
21. Prognostic significance of Nemo-like kinase expression in patients with hepatocellular carcinoma.
Chen HW; Qiao HY; Li HC; Li ZF; Zhang HJ; Pei L; Liu HW; Jin L; Wang D; Li JL
Tumour Biol; 2015 Nov; 36(11):8447-53. PubMed ID: 26022162
[TBL] [Abstract][Full Text] [Related]
22. Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance.
Gorrin Rivas MJ; Arii S; Furutani M; Harada T; Mizumoto M; Nishiyama H; Fujita J; Imamura M
Hepatology; 1998 Oct; 28(4):986-93. PubMed ID: 9755235
[TBL] [Abstract][Full Text] [Related]
23. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.
Fang F; Yang L; Tao Y; Qin W
Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761
[TBL] [Abstract][Full Text] [Related]
24. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940
[TBL] [Abstract][Full Text] [Related]
25. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma.
Tsuboi Y; Ichida T; Sugitani S; Genda T; Inayoshi J; Takamura M; Matsuda Y; Nomoto M; Aoyagi Y
Liver Int; 2004 Oct; 24(5):432-6. PubMed ID: 15482339
[TBL] [Abstract][Full Text] [Related]
27. Down-regulated expression of the protein-tyrosine phosphatase 1B (PTP1B) is associated with aggressive clinicopathologic features and poor prognosis in hepatocellular carcinoma.
Zheng LY; Zhou DX; Lu J; Zhang WJ; Zou DJ
Biochem Biophys Res Commun; 2012 Apr; 420(3):680-4. PubMed ID: 22450318
[TBL] [Abstract][Full Text] [Related]
28. Expression of metallothionein-1 and metallothionein-2 as a prognostic marker in hepatocellular carcinoma.
Park Y; Yu E
J Gastroenterol Hepatol; 2013 Sep; 28(9):1565-72. PubMed ID: 23662831
[TBL] [Abstract][Full Text] [Related]
29. Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.
Xu K; Gao J; Yang X; Yao Y; Liu Q
Oncol Rep; 2013 Jun; 29(6):2211-8. PubMed ID: 23545718
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
[TBL] [Abstract][Full Text] [Related]
31. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
[TBL] [Abstract][Full Text] [Related]
32. HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.
Zhao YM; Zhou JM; Wang LR; He HW; Wang XL; Tao ZH; Sun HC; Wu WZ; Fan J; Tang ZY; Wang L
Cancer; 2012 May; 118(10):2708-17. PubMed ID: 21989785
[TBL] [Abstract][Full Text] [Related]
33. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
35. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
38. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
39. p21-activated kinase 6 controls mitosis and hepatocellular carcinoma progression by regulating Eg5.
Zheng J; Zhang C; Li Y; Jiang Y; Xing B; Du X
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118888. PubMed ID: 33098954
[TBL] [Abstract][Full Text] [Related]
40. High expression of vacuolar protein sorting 4B (VPS4B) is associated with accelerated cell proliferation and poor prognosis in human hepatocellular carcinoma.
Jiang D; Hu B; Wei L; Xiong Y; Wang G; Ni T; Zong C; Ni R; Lu C
Pathol Res Pract; 2015 Mar; 211(3):240-7. PubMed ID: 25547899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]